Humira, Enbrel Face Pricing Pressures From Copay Accumulator Programs

Payer efforts to undercut copay assistance are getting manufacturers’ attention. PhRMA launches ad campaign warning patients that 'middlemen' are 'trying to keep you from reaching your deductible.'